Home › Funds › PSP Research LLC › IMNM

PSP Research LLC position in IMNM

IMMUNOME INC · Health Care

PSP Research LLC reported holding 12,000 shares of IMNM (IMMUNOME INC) in its Q3 2026 13F filing — a position valued at US$258K, representing 0.18% of its reported portfolio and ranking #16 among its reported holdings. PSP Research LLC has disclosed IMNM holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)12.00K sh
Reported value held$258.12K
Portfolio Weight0.18%
First reportedQ4 2025
Last changeReduce
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How PSP Research LLC's IMNM position evolved

PSP Research LLC first disclosed a stake in IMNM in Q4 2025 at 25,245 shares (US$542K). Across 4 filings, PSP Research LLC increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 12,000 shares valued at US$258K — a reduction of -6,000 shares quarter over quarter.. Notable position changes include a 33% trim in Q3 2026 (shares fell 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 25.25K $542.26K New
Q1 2026 20.00K $437.40K Reduce
Q2 2026 18.00K $381.42K Reduce
Q3 2026 12.00K $258.12K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMNM and 13F data

IMNM (IMMUNOME INC) is a Health Care company. 49 other funds we track also report a position in IMNM — the largest reported positions include Redmile Group, LLC (US$104.1M), Enavate Sciences GP, LLC (US$76.6M), SILVERARC CAPITAL MANAGEMENT, LLC (US$42.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMNM

All IMNM fund holders →

FAQ

How long has PSP Research LLC held IMNM?

PSP Research LLC has disclosed IMNM holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is PSP Research LLC's current position in IMNM?

As of Q3 2026, PSP Research LLC holds 12.00K shares of IMNM (IMMUNOME INC), valued at $258.12K, representing 0.18% of its reported portfolio and ranking #16.

Has PSP Research LLC been buying or selling IMNM?

In the latest 13F filing (Q3 2026), PSP Research LLC reduced its position in IMNM.

Which other funds hold IMNM?

Other major institutional holders of IMNM include Redmile Group, LLC, Enavate Sciences GP, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.